(4aS,5R)-5-(2-(2-(cyclopropylsulfonyl)phenyl)ethyl)-1-(4-fluorophenyl)-4a-methyl-1,4,4a,5,6,7-hexahydrocyclopenta[f]indazol-5-ol | 1021538-75-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子
• 英文名称: (4aS,5R)-5-(2-(2-(cyclopropylsulfonyl)phenyl)ethyl)-1-(4-fluorophenyl)-4a-methyl-1,4,4a,5,6,7-hexahydrocyclopenta[f]indazol-5-ol
• 英文别名: (4aS,5R)-5-[2-(2-cyclopropylsulfonylphenyl)ethyl]-1-(4-fluorophenyl)-4a-methyl-6,7-dihydro-4H-cyclopenta[f]indazol-5-ol
• CAS: 1021538-75-9
• 化学式: C₂₈H₂₉FN₂O₃S
• 分子量: 492.614
• InChiKey: XYYQBENCDMHGCZ-NSOVKSMOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  35
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  80.6
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
  申请人：Bungard Christopher J.

  公开号：US20100311709A1

  公开（公告）日：2010-12-09

  The present invention is directed to 2-[ 1 -phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives of formula I (I) as glucocorticoid receptor ligands useful for treating a variety of autoimmune and inflammatory diseases or conditions. Pharmaceutical compositions and methods of use are also included.

  本发明涉及公式I（I）的2-[1-苯基-5-羟基或甲氧基-4α-甲基-六氢环戊[f]吲唑-5-基]乙基苯基衍生物，作为糖皮质激素受体配体，用于治疗各种自身免疫和炎症性疾病或症状。还包括制药组合物和使用方法。
• US8119681B2
  申请人：——

  公开号：US8119681B2

  公开（公告）日：2012-02-21
• [EN] 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS<br/>[FR] DÉRIVES DE 2-[1-PHÉNYL-5-HYDROXY OU METHOXY-4ALPHA-MÉTHYL-HEXAHYDROCLOPENTA[F]INDAZOL-5-YL]ÉTHYLE PHÉNYLE UTILISES COMME LIGANDS DE RÉCEPTEUR DE GLUCOCORTICOIDE
  申请人：MERCK & CO INC

  公开号：WO2008051532A1

  公开（公告）日：2008-05-02

  [EN] The present invention is directed to 2- [l-phenyl-5 -hydroxy or methoxy-4alpha- methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives of formula I (I) as glucocorticoid receptor ligands useful for treating a variety of autoimmune and inflammatory diseases or conditions. Pharmaceutical compositions and methods of use are also included.
  [FR] L'invention concerne des derivés de 2- [l-phényl-5 -hydroxy ou méthoxy-4alpha- méthyl-hexahydrocyclopenta[f]indazol-5-yl]éthyle phényle correspondant à la formule (I) utilisés comme ligands de récepteur de glucocorticoïde utiles dans le traitement de diverses maladies ou états auto-immunes ou inflammatoires. L'invention concerne également des compositions pharmaceutiques et des procédés d'utilisation.